平民创伤中大量输注全血与成分输血的安全性比较
这项回顾性队列分析比较了平民创伤患者接受成分输血(COMP组,2017年1月至2018年6月)与成分输血加全血(WB组,2018年7月至2019年1月全血可用后)的复苏效果。共纳入42例WB组和83例COMP组患者,两组基线特征相似,中位年龄41岁,73%为男性,30%为穿透伤,中位损伤严重度评分29。WB组中位接受6.5单位全血,接受了显著更多的成分等效单位,血浆/红细胞比值为0.94:1 vs COMP组0.8:1(p<0.001)。24小时死亡率(COMP 27% vs WB 29%,p=0.8)和30天死亡率(COMP 46% vs WB 58%,p=0.2)均无显著差异,无输血反应。作者认为全血作为成分输血的补充是安全有效的,可能实现更平衡的复苏,但总体血制品用量更多。
要点
- 平民创伤患者大量输注全血(中位6.5单位)与成分输血相比,24小时死亡率(COMP 27% vs WB 29%,p=0.8)和30天死亡率(COMP 46% vs WB 58%,p=0.2)均无显著差异。
- WB组接受了显著更多的成分等效单位,血浆/红细胞比值为0.94:1 vs COMP组0.8:1(p<0.001),提示可能实现更平衡的复苏但总体血制品用量更多。
- 两组均无输血反应报告。
- 作者认为全血作为成分输血的补充在平民创伤中是安全有效的,即使大量输注也可行。
- 本研究为回顾性队列分析,证据等级为治疗性研究Level IV。
适用人群与场景
- 平民创伤患者,纳入条件为入院24小时内接受1单位全血或红细胞且启动大量输血方案。
- COMP组为2017年1月至2018年6月就诊的患者,WB组为2018年7月至2019年1月全血可用后就诊的患者。
处置流程与药物剂量
- WB组接受未经交叉配血的冷藏低效价O型阳性或阴性全血,中位6.5单位(IQR 3-11)。
- 分析时1单位全血等效于1单位红细胞、1单位血浆和1/6单位血小板。
研究设计与关键结果
- 回顾性队列分析,42例接受全血(WB组),83例接受成分输血(COMP组),两组基线特征相似。
- 中位年龄41岁(IQR 28-61岁),73%为男性,30%为穿透伤,中位损伤严重度评分29(IQR 17-38)。
- WB组接受中位6.5单位全血(IQR 3-11),接受了显著更多的成分等效单位,血浆/红细胞比值0.94:1 vs COMP组0.8:1(p<0.001)。
- 24小时死亡率:COMP组27% vs WB组29%(p=0.8),无显著差异。
- 30天死亡率:COMP组46% vs WB组58%(p=0.2),无显著差异。
- 无输血反应报告。
证据类型、等级与局限
- 治疗性研究,证据等级Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,平民创伤中主要使用全血进行输血是可行的,即使大量输注;似乎是成分输血的安全有效补充,可能实现更平衡的复苏,但总体血制品用量更多。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Transfusion with uncrossmatched cold-stored low-titer group O-positive or -negative whole blood (WB) in civilian trauma has been investigated as an alternative to component therapy but only in limited volumes. To our knowledge, this is the first analysis of the safety and efficacy of large volume transfusion of patients with trauma with WB.
METHODS: This is a retrospective cohort analysis comparing trauma patients resuscitated with component therapy (COMP) versus component therapy plus WB. The COMP group was comprised of patients who presented from January 2017 through June 2018 and the WB group from patients who presented from July 2018 through January 2019 after WB became available. We included patients if they received 1 unit of WB or red blood cells (RBCs) within 24 hours of admission and had massive transfusion protocol activated. We used bivariate analysis to compare groups. For analysis, one unit of WB equaled 1 unit of RBCs, 1 unit of plasma, and 1/6 of a unit of platelets.
RESULTS: Forty-two patients received WB and 83 patients received COMP with similar baseline characteristics. Patients had a median age of 41 years (interquartile range [IQR], 28-61 years) and 73% were male. Thirty percent had penetrating injuries with a median Injury Severity Score of 29 (IQR, 17-38). The WB group received a median of 6.5 units (IQR, 3-11). The WB group received significantly more component-equivalent units but with a plasma/RBC ratio of 0.94:1 compared with 0.8:1 (p < 0.001). There were no differences in 24-hour mortality (COMP, 27% vs. WB, 29%, p = 0.8) or 30-day mortality (COMP, 46% vs. WB, 58% p = 0.2). There were no transfusion reactions.
CONCLUSION: Transfusion utilizing primarily WB in civilian trauma is feasible, even in large volumes. It appears to be a safe and effective addition to component therapy and may lead to a more balanced resuscitation but with more overall product used.
LEVEL OF EVIDENCE: Therapeutic study, Level IV.
参考来源
- Gallaher JR, Dixon A, Cockcroft A, et al. Large volume transfusion with whole blood is safe compared with component therapy. J Trauma Acute Care Surg. 2020. PMID: 32574485. doi:10.1097/TA.0000000000002687
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。